Dong Zhou
439 XuanHua Road
Yongchuan, 402160, China
Yongchuan, 402160, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Publisher Correction: SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.
Journal: Nature cell biology
Published: January 19, 2026
Global trends and research hotspots in coronary revascularization for ischemic heart disease: a bibliometric analysis (2005-2024).
Journal: Journal of cardiothoracic surgery
Published: August 22, 2025
Survival outcomes and predictors following coronary artery bypass grafting in patients with preoperative left ventricular dysfunction.
Journal: BMC cardiovascular disorders
Published: August 11, 2025
SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.
Journal: Nature cell biology
Published: June 02, 2025
PIN1 serves as a prognostic and therapeutic biomarker in lung adenocarcinoma.
Journal: Functional & integrative genomics
Published: April 17, 2025
SUSD2 hypersialylation promotes early lung adenocarcinoma progression by driving ECM remodeling and pro-tumorigenic fibroblast activation.
Journal: Cancer letters
Published: March 19, 2025
Senescent SPP1+ macrophages remodel the tumor microenvironment and promote the progression of early-stage lung adenocarcinoma featured with mixed ground glass nodule.
Journal: Molecular cancer
Published: January 16, 2025
Efficiency and safety of neoadjuvant PD-1 inhibitor (penpulimab) combined with chemotherapy in resectable N1/N2 nonsmall cell lung cancer: a prospective cohort study.
Journal: International journal of surgery (London, England)
Published: December 27, 2024
DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps.
Journal: Cancer cell
Published: November 12, 2024
Integrated multi-omics and machine learning reveal a gefitinib resistance signature for prognosis and treatment response in lung adenocarcinoma.
Journal: IUBMB life
Published: August 03, 2024
A novel enemy of cancer: recent investigations into protozoan anti-tumor properties.
Journal: Frontiers in cellular and infection microbiology
Published: November 17, 2023
Integrated whole-exome and bulk transcriptome sequencing delineates the dynamic evolution from preneoplasia to invasive lung adenocarcinoma featured with ground-glass nodules.
Journal: Cancer medicine
Published: October 03, 2023
Last Updated: 09/26/2026